SIRECUST 400 SYSTEM PATIENT MONITORING— 510(k) K802113

Substantially Equivalent

Analogic Corp.

FDA 510(k) clearance K802113 for SIRECUST 400 SYSTEM PATIENT MONITORING, Substantially Equivalent on 1981-01-22. Applicant: Analogic Corp..

Clearance details

Applicant: Analogic Corp.
Product code: Code DPS
Advisory panel: Cardiovascular
Date received: 1980-09-03
Decision date: 1981-01-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code DPS

product code DPS

Death: 7
Total: 7

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.